Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/43173
Tipo
ArtículoDerechos de autor
Acceso restringido
Fecha del embargo
2022-01-01
Colecciones
- IOC - Artigos de Periódicos [12514]
Metadatos
Mostrar el registro completo del ítem
SCHISTOSOMA MANSONI CATHEPSIN D1: BIOCHEMICAL AND BIOPHYSICAL CHARACTERIZATION OF THE RECOMBINANT ENZYME EXPRESSED IN HEK293T CELLS
Schistosome
HEK 293T cells
Analytical ultracentrifugation
SEC-MALS
Dimer
Afiliación
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Bioquímica Experimental e Computacional de Fármacos. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Bioquímica Experimental e Computacional de Fármacos. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Bioquímica Experimental e Computacional de Fármacos. Rio de Janeiro, RJ, Brasil.
Research Complex at Harwell, R92 Rutherford Appleton Laboratory. Didcot, UK
Research Complex at Harwell, R92 Rutherford Appleton Laboratory. Didcot, UK / Henry Wellcome Building for Genomic Medicine. The Division of Structural Biology. Oxford, UK.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Bioquímica Experimental e Computacional de Fármacos. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Bioquímica Experimental e Computacional de Fármacos. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Bioquímica Experimental e Computacional de Fármacos. Rio de Janeiro, RJ, Brasil.
Research Complex at Harwell, R92 Rutherford Appleton Laboratory. Didcot, UK
Research Complex at Harwell, R92 Rutherford Appleton Laboratory. Didcot, UK / Henry Wellcome Building for Genomic Medicine. The Division of Structural Biology. Oxford, UK.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Bioquímica Experimental e Computacional de Fármacos. Rio de Janeiro, RJ, Brasil.
Resumen en ingles
Schistosomes express a variety of aspartyl proteases (APs) with distinct roles in the helminth pathophysiology,
among which degradation of host haemoglobin is key, since it is the main amino acid source for these parasites.
A cathepsin D-like AP from Schistosoma mansoni (SmCD1) has been used as a model enzyme for vaccine and drug
development studies in schistosomes and yet a reliable expression system for readily producing the recombinant
enzyme in high yield has not been reported. To contribute to further advancing the knowledge about this valuable antischistosomal target, we developed a transient expression system in HEK 293T mammalian cells and
performed a biochemical and biophysical characterization of the recombinant enzyme (rSmCD1). It was possible
to express a recombinant C-terminal truncated form of SmCD1 (rSmCD1ΔCT) and purify it with high yield
(16 mg/L) from the culture supernatant. When analysed by Size-Exclusion Chromatography and multi-angle
laser light scattering, rSmCD1ΔCT behaved as a dimer at neutral pH, which is unusual for cathepsins D, turning
into a monomer after acidification of the medium. Through analytical ultrancentrifugation, the dimer was
confirmed for free rSmCD1ΔCT in solution as well as stabilization of the monomer during interaction with
pepstatin. The mammalian cell expression system used here was able to produce rSmCD1ΔCT with high yields
allowing for the first time the characterization of important kinetic parameters as well as initial description of its
biophysical properties.
Palabras clave en ingles
Cathepsin DSchistosome
HEK 293T cells
Analytical ultracentrifugation
SEC-MALS
Dimer
Compartir